About Us

The Most Established Precision Molecular Diagnostics Company in Indonesia

Founded in 2020, Nusantics changed the molecular diagnostics landscape in Indonesia. Our technology has been used in more than 8 million tests during the COVID-19 pandemic. Now, we look to expand our technology to change the way we diagnose communicable diseases and oncology.

hero-about-us
logo-dark
logo-dark

Leading the Way in Molecular Diagnostics

At Nusantics, we believe that molecular diagnosis should be accessible, affordable, and at a massive scale. Our products supports our customers across the continuum of molecular diagnostics. From the novel, non-invasive sampling method, DNA and RNA extraction, to PCR and NGS kits targeting single or multiple molecular target, and bioinformatics pipeline to analyze and interpret molecular data to deliver valuable insights.

icon-vision

Our Vision

We envision a healthy world enabled by genomics, microbiomics, and precision medicine

icon-vision

Our Mission

To close the diagnostics gap and improve healthcare outcome for both humans and animals


Our Core Values

The Principle to Guide Us on Our Journey

They embody what we stand for and guide our approach to how we build our product to improve healthcare outcomes.

icon-core-value

Innovation

The foundation of imagination and creativity, embracing challenges, and openness to change.

icon-core-value

Collaboration

Building an environment of trust, teamwork & collaboration, and valuing people internally and externally.

icon-core-value

Integrity

Embedding every action with integrity, respect, and a commitment to ethical conduct, even in the absence of oversight.

icon-core-value

Quality

Our dedication to quality involves meticulous reviews and continuous improvements to ensure the highest standard in our products.

icon-core-value

Meritocratic

Transparent communication, growth opportunities, and merit-based recognition foster diversity and equity in the workplace.

Our Story

description-image

The Journey that Shapes Our Mission

Nusantics's journey began in 2020 with a research focus on how microbiome affects our health. Since the COVID-19 pandemic, Our focus shifted to democratize molecular diagnosis.
  • The founding of Nusantics (2020)

    Nusantics was founded to personalize skin health with its novel Biome Scan. We are backed by East Ventures.

  • The launching of mBioCoV-19 (2020)

    COVID-19 was declared a pandemic in Indonesia. We helped to make COVID-19 PCR testing more accessible with our BioCoV-19 and mBioCoV-19 in collaboration with Biofarma. Since then, we pivoted to building precision molecular diagnostics.

  • The launching of BioSaliva and VarScreen (2021)

    Together with Biofarma, Nusantics released the non-invasive sampling method for COVID-19 PCR using gargle, named BioSaliva. VarScreen was launched to help diagnose the COVID-19 variant without Whole Genome Sequencing, reducing the cost of testing.

  • Illumina invested in Nusantics and the introduction of ShrimProtect and CeKolam (2022)

    mBioCoV- 19 reached 8,000,000 tests across Indonesia.
    ShrimProtect and CeKolam Initiative were launched to help shrimp farmers detect pathogens early to mitigate the high mortality rate.

  • PathoScan hrHPV for cervical cancer screening (2023)

    PathoScan hrHPV was launched to help Indonesian women detect HPV early in order to prevent the development of cervical cancer.


Meet the People behind Nusantics!

Our Founders and C-Levels

Revata Utama

Revata Utama

Founder & CEO

Revata Utama

Revata Utama

Founder & CEO

Our Management

Reskha Handayani

Reskha Handayani

Head of BU Animal Diagnostics

Evita Irmayanti

Evita Irmayanti

Research Collaboration Manager

Palupi P. Dewi

Palupi P. Dewi

Head of Technical Operations

Jason Limanjaya

Jason Limanjaya

Head of Digital Products

Muhamad Normansyah

Muhamad Normansyah

Head of Legal & Compliance

Alfred Markus Jevon Tehubyuluw

Alfred Markus Jevon Tehubyuluw

Head of Finance & Accounting

Reskha Handayani

Reskha Handayani

Head of BU Animal Diagnostics

Evita Irmayanti

Evita Irmayanti

Research Collaboration Manager

Palupi P. Dewi

Palupi P. Dewi

Head of Technical Operations

Jason Limanjaya

Jason Limanjaya

Head of Digital Products

Muhamad Normansyah

Muhamad Normansyah

Head of Legal & Compliance

Alfred Markus Jevon Tehubyuluw

Alfred Markus Jevon Tehubyuluw

Head of Finance & Accounting

Our Board of Advisors

Triawan Munaf

Triawan Munaf

Commissioner

Carl T. Wittwer, MD, PhD

Carl T. Wittwer, MD, PhD

Senior Scientific Advisor

Sidrotun Naim, MS, MPA, PhD

Sidrotun Naim, MS, MPA, PhD

Scientific Advisor - Shrimp Diagnostics

Triawan Munaf

Triawan Munaf

Commissioner

Carl T. Wittwer, MD, PhD

Carl T. Wittwer, MD, PhD

Senior Scientific Advisor

Sidrotun Naim, MS, MPA, PhD

Sidrotun Naim, MS, MPA, PhD

Scientific Advisor - Shrimp Diagnostics


Utilize Our Technology in Your Lab

Let’s improve healthcare outcomes together! We are here to help clinical laboratories make molecular diagnosis accessible and affordable for all.

consultation
logo-dark
logo-dark

The most established precision molecular diagnostics company in Indonesia

Find Us

Mon - Fri: 9 a.m. - 6 p.m.

i3L Campus @ Lvl. 3
Jl. Pulomas Barat No.Kav.88, RT.4/RW.9, Kayu Putih, Pulo Gadung,
Jakarta Timur 13210

Contact Us

hello@nusantics.com

+62 (21) 509 194 30

Copyright © 2024 PT Riset Nusantara Genetika, PT Nusantara Butuh Diagnostik. All Rights Reserved.Privacy Policy

logo-dark
logo-dark

© 2024 PT Riset Nusantara Genetika.

Privacy Policy